Return
Reduced Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma – a Phase II Study
C
S
C
S
S
K
M
A
M
A
L
DOI:10.1016/j.jtct.2026.06.034.png)
Abstract
En
Journal
IF:
4.4
Papers:
2.1K
Citations:
4.4K
